SCHEMBL23635919

SCHEMBL23635919

CCOC(=O)c1sc2cccc(Cl)c2c1COc1ccc(C(N)=O)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 9/20 0.57
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 2/20 0.56
MAPK1 P28482 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MCL1 Q07820 3/20 0.42
MRGPRX4 Q96LA9 2/20 0.41
MAPT P10636 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MITF O75030 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30697667 1.00 STING1 (0.57) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL23635917 0.92 STING1 (0.55) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL30697669 0.92 STING1 (0.55) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL30697670 0.89 STING1 (0.53) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL23635920 0.89 STING1 (0.53) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL23635874 0.88 STING1 (0.66) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL30697683 0.88 STING1 (0.66) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL23635875 0.87 ALDH1A1 (0.59) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL30697675 0.87 ALDH1A1 (0.59) STING1KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL23630808 0.87 STING1 (0.62) STING1MAPK1MCL1MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD. (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885KDM4E 1469/4885ALDH1A1 4660/4885
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885KDM4E 1519/4885ALDH1A1 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.